Milestone Pharmaceuticals is trading 5.48% up in pre-market at $0.97, after rising from the September 17 close of $0.92 amid constructive broader-market sentiment.
- No new company-specific announcement, analyst action, or direct catalyst was identified for September 18, 2026.
- Nasdaq futures were up 0.68%, while global equities responded positively to the Bank of Japan’s gradual rate increase.